Skip to main content
. 2017 Feb 6;8(14):22524–22533. doi: 10.18632/oncotarget.15121

Figure 3. Cellular anti-HIV-1 factors expression in PBMCs of HIV-1-infected subjects on cART.

Figure 3

PBMCs were collected from HIV-1-infected subjects (n = 18) prior to (0 m) or 1 month (1 m), 3 months (3 m), and 6 months (6 m) after cART. Age-matched healthy subjects (n = 18) were used as a control group. Cellular RNAs extracted from PBMCs were subjected to quantitative PCR for anti-HIV-1 factors (OAS-1, MxA, A3G, Tetherin, PKR, ISG56). The expression levels were shown relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and the significant differences from paired or unpaired t tests were shown by *p < 0.05, **p < 0.01, and ***p < 0.001.